Catheter ablation of atrial fibrillation:: Where do we stand now

被引:0
|
作者
Jaïs, P [1 ]
Haïssaguerre, M [1 ]
Clémenty, J [1 ]
机构
[1] Hop Cardiol Haut Leveque, F-33604 Pessac, France
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation is the commonest arrhythmia. Besides the risk of complications, a significant number of patients remain symptomatic despite the different antiarrhythmic drugs currently available. The only curative treatment is by surgery or catheter ablation. Since 1994, several approaches have been developed based on two main concepts: modification of the arrhythmogenic substrate by linear lesion to prevent the perpetuation of the arrhythmia and ablation of the foci initiating the atrial fibrillation. The later approach is the most popular one at the moment because the concentration of foci at the site of the pulmonary veins makes it possible to isolate them relatively easily. The presence of atrial foci in some patients complicates matters and limits the success rate to 70%. Despite these limitations and with an acceptable rate of complications, this approach appears preferable to His bundle ablation in young patients with symptomatic paroxysmal atrial fibrillation resistant to antiarrhythmic therapy.
引用
收藏
页码:1087 / 1092
页数:6
相关论文
共 50 条
  • [41] Atrial fibrillation in chronic non-cardiac disease: Where do we stand?
    Lainscak, Mitja
    Dagres, Nikolaos
    Filippatos, Gerasimos S.
    Anker, Stefan D.
    Kremastinos, Dimitrios Th.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 128 (03) : 311 - 315
  • [42] CATHETER ABLATION FOR ATRIAL FIBRILLATION We should be optimistic about ablation for atrial fibrillation Reply
    Van Brabandt, Hans
    Neyt, Mattias
    Devos, Carl
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [43] Catheter Ablation of Atrial Fibrillation in Persons With HFpEF We Can All Breathe Easier Now!
    Deswal, Anita
    Piccini, Jonathan P.
    [J]. JACC-HEART FAILURE, 2023, 11 (06) : 659 - 661
  • [44] The place of ablation in the treatment of atrial fibrillation:: where are we and where are we going
    Jaïs, P
    Hocini, M
    Sacher, F
    Clémenty, J
    Haïssaguerre, M
    [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2004, 97 (11): : 1071 - 1077
  • [45] Catheter Ablation of Persistent AF-Where are We Now?
    O'Neill, Louisa
    De Becker, Benjamin
    De Smet, Maarten A. J.
    Francois, Clara
    Tavernier, Rene
    Duytschaever, Mattias
    Knecht, Sebastien
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (12)
  • [46] Iatrogenic atrial septal defect after catheter ablation of atrial fibrillation: do we have to worry?
    Sommer, Philipp
    Hindricks, Gerhard
    [J]. EUROPACE, 2010, 12 (03): : 301 - 302
  • [47] Genetic Architecture of Depression: Where Do We Stand Now?
    Unal-Aydin, Pinar
    Aydin, Orkun
    Arslan, Ayla
    [J]. MAJOR DEPRESSIVE DISORDER: RETHINKING AND UNDERSTANDING RECENT DISCOVERIES, 2021, 1305 : 203 - 230
  • [48] Low Dose CT: Where Do We Stand Now?
    Leng, Shuai
    Chen, G.
    Stayman, J.
    McCollough, C.
    Pickhardt, P.
    [J]. MEDICAL PHYSICS, 2017, 44 (06) : 3248 - 3249
  • [49] Antioxidants and CVD in diabetes: Where do we stand now?
    Yim S.
    Malhotra A.
    Veves A.
    [J]. Current Diabetes Reports, 2007, 7 (1) : 8 - 13
  • [50] Accelerated Approval of Aducanumab: Where Do We Stand Now?
    Barenholtz Levy, Hedva
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (06) : 736 - 739